A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies – Nashville, TN
This activity will cover the treatment and management of patients with AML and CLL.
This activity will cover the treatment and management of patients with AML and CLL.
This activity will cover the treatment and management of patients with AML and CLL.
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This case-based live activity will cover the treatment and management of patients with hemophilia A
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.
This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).